Showing results (41-50 of 49) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 49 results.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|February 20, 2004
Identification and characterization of choline transporter-like protein 2, an inner ear glycoprotein of 68 and 72 kDa that is the target of antibody-induced hearing lossThankam S Nair, Kelley E Kozma, Nickoleta L Hoefling, et al.
Rheumatology (Oxford, England)|October 30, 2024
Comparative effects of biological and targeted synthetic DMARDs on incident chronic kidney disease in patients with rheumatoid arthritisNozomi Nishimura, Akira Onishi, Wataru Yamamoto, et al.
Rheumatology (Oxford, England)|February 6, 2024
Comparison of retention of biologics in Japanese patients with elderly-onset rheumatoid arthritis-the ANSWER cohort studySadao Jinno, Akira Onishi, Shuhei Hattori, et al.
RMD Open|August 19, 2023
Drug retention of biologics and Janus kinase inhibitors in patients with rheumatoid arthritis: the ANSWER cohort studyKosuke Ebina, Yuki Etani, Yuichi Maeda, et al.
International Journal of Rheumatic Diseases|March 5, 2024
Association of large joint involvement at the start of biological disease-modifying antirheumatic drugs and Janus kinase inhibitors with disease activity and drug retention in patients with rheumatoid arthritis: The ANSWER cohort studyIku Shirasugi, Akira Onishi, Keisuke Nishimura, et al.
Rheumatology (Oxford, England)|October 4, 2023
Trends of disease activity in Japanese patients over 75 years with rheumatoid arthritis from 2014 to 2021: the ANSWER cohort studyHirotaka Yamada, Sadao Jinno, Toshihisa Maeda, et al.
Rheumatology (Oxford, England)|November 4, 2023
Real-world comparative study of the efficacy of Janus kinase inhibitors in patients with rheumatoid arthritis: the ANSWER cohort studyShinya Hayashi, Shotaro Tachibana, Toshihisa Maeda, et al.
Modern Rheumatology|May 26, 2023
Associations of disease duration and anti-citrullinated peptide antibody status with the effectiveness of abatacept in biologic-naïve patients with rheumatoid arthritis: Post hoc analysis of a multicentre, real-world observational study in Japan (ORIGAMI)Kenta Misaki, Naoto Tamura, Takanori Azuma, et al.
Plos One|March 18, 2026
Mode of action-specific and cause-specific retention of biologic and targeted synthetic disease-modifying antirheumatic drugs in anti-SS-A antibody-positive rheumatoid arthritis: The ANSWER cohort studyKazuma Nishisaka, Takaichi Okano, Takumi Imai, et al.
Pageof 5